Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009
May 07 2009 - 9:00AM
PR Newswire (US)
Conference Call to Follow Release DENVER, May 7
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international healthcare information technology company, will
report its first quarter financial results on Friday, May 15, 2009,
in a pre-market press release. The Company will host a conference
call at 11:00 a.m. Eastern on the same day. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Dr.
Mick Ruxin, Chief Executive Officer, Tom Marcinek, President and
Chief Operating Officer, and Karen Davis, Chief Financial Officer,
will discuss the first quarter financial results, as well as major
company developments, and will be available to answer questions.
The conference call will be held on May 15, 2009, at 11:00 a.m.
Eastern. Interested parties are welcome to call the telephone
numbers listed below five minutes prior to the start of the
conference call. Callers within the U.S. should call:
1-866-394-9731. Callers that are outside of the U.S. should call:
1-706-643-7541. Callers should reference "Global Med First Quarter
Financial Results" to the conference call operator. The conference
call ID number will be: 98847282. An automated replay of the
conference call will be available from Friday, May 15, 2009 at 5:30
p.m. Eastern until Tuesday, May 19, 2009 at 11:59 p.m. Eastern. To
access the replay, callers within the U.S. should call:
1-800-642-1687. Callers outside of the U.S. should call:
1-706-645-9291 and enter Global Med's access code of 98847282. The
replay of the conference call will be available from May 18, 2009
onward at Global Med's website at http://www.globalmedtech.com/.
About Global Med Technologies(R), Inc. Global Med Technologies,
Inc. is an international healthcare information technology company
which develops regulated and non-regulated products and services
for the healthcare industry. As a leading provider of blood and
laboratory systems and services, Global Med's products are deployed
in 20 countries and serve over 2,100 transfusion centers, blood
banks and laboratory sites. Global Med's domestic companies are
Wyndgate Technologies(R), a leader in software products and
services for donor centers and hospital transfusion services;
eDonor(R), which offers web-based donor relationship management
systems; and PeopleMed(TM), Inc., which implements cost-effective
software validation, consulting and compliance solutions to
hospitals and donor centers. Global Med's European subsidiary,
Inlog, SA, is a leading developer of donor center and transfusion
management systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. For more information about Global Med's products
and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Karen Davis, CFO of Global
Med Technologies, Inc., +1-916-404-8495, Web Site:
http://www.globalmedtech.com/
Copyright